331 related articles for article (PubMed ID: 37460938)
21. Organoid in colorectal cancer: progress and challenges.
Ji DB; Wu AW
Chin Med J (Engl); 2020 Aug; 133(16):1971-1977. PubMed ID: 32826461
[TBL] [Abstract][Full Text] [Related]
22. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
23. Modeling tumor development and metastasis using paired organoids derived from patients with colorectal cancer liver metastases.
Li H; Dai W; Xia X; Wang R; Zhao J; Han L; Mo S; Xiang W; Du L; Zhu G; Xie J; Yu J; Liu N; Huang M; Zhu J; Cai G
J Hematol Oncol; 2020 Sep; 13(1):119. PubMed ID: 32883331
[TBL] [Abstract][Full Text] [Related]
24. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines.
Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z
Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer.
Voß H; Wurlitzer M; Smit DJ; Ewald F; Alawi M; Spohn M; Indenbirken D; Omidi M; David K; Juhl H; Simon R; Sauter G; Fischer L; Izbicki JR; Molloy MP; Nashan B; Schlüter H; Jücker M
Clin Exp Metastasis; 2020 Dec; 37(6):649-656. PubMed ID: 33099724
[TBL] [Abstract][Full Text] [Related]
26. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Pennel KAF; Hatthakarnkul P; Wood CS; Lian GY; Al-Badran SSF; Quinn JA; Legrini A; Inthagard J; Alexander PG; van Wyk H; Kurniawan A; Hashmi U; Gillespie MA; Mills M; Ammar A; Hay J; Andersen D; Nixon C; Rebus S; Chang DK; Kelly C; Harkin A; Graham J; Church D; Tomlinson I; Saunders M; Iveson T; Lannagan TRM; Jackstadt R; Maka N; Horgan PG; Roxburgh CSD; Sansom OJ; McMillan DC; Steele CW; Jamieson NB; Park JH; Roseweir AK; Edwards J
J Exp Clin Cancer Res; 2024 Mar; 43(1):64. PubMed ID: 38424636
[TBL] [Abstract][Full Text] [Related]
27. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.
Ooft SN; Weeber F; Dijkstra KK; McLean CM; Kaing S; van Werkhoven E; Schipper L; Hoes L; Vis DJ; van de Haar J; Prevoo W; Snaebjornsson P; van der Velden D; Klein M; Chalabi M; Boot H; van Leerdam M; Bloemendal HJ; Beerepoot LV; Wessels L; Cuppen E; Clevers H; Voest EE
Sci Transl Med; 2019 Oct; 11(513):. PubMed ID: 31597751
[TBL] [Abstract][Full Text] [Related]
28. A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases.
Jian M; Ren L; He G; Lin Q; Tang W; Chen Y; Chen J; Liu T; Ji M; Wei Y; Chang W; Xu J
J Transl Med; 2020 Jun; 18(1):234. PubMed ID: 32532289
[TBL] [Abstract][Full Text] [Related]
29. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
[TBL] [Abstract][Full Text] [Related]
30. Renin-Angiotensin Inhibitor, Captopril, Attenuates Growth of Patient-Derived Colorectal Liver Metastasis Organoids.
Riddiough GE; Fifis T; Muralidharan V; Christophi C; Tran BM; Perini MV; Vincan E
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542253
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.
Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J
J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
[TBL] [Abstract][Full Text] [Related]
33. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
34. Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors.
Wang R; Li J; Zhou X; Mao Y; Wang W; Gao S; Wang W; Gao Y; Chen K; Yu S; Wu X; Wen L; Ge H; Fu W; Tang F
Genome Med; 2022 Aug; 14(1):93. PubMed ID: 35974387
[TBL] [Abstract][Full Text] [Related]
35. The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.
Orjuela S; Menigatti M; Schraml P; Kambakamba P; Robinson MD; Marra G
BMC Cancer; 2020 Apr; 20(1):290. PubMed ID: 32252665
[TBL] [Abstract][Full Text] [Related]
36. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
[TBL] [Abstract][Full Text] [Related]
37. Delivery of Engineered Primary Tumor-Derived Exosomes Effectively Suppressed the Colorectal Cancer Chemoresistance and Liver Metastasis.
Huang C; Zhou Y; Feng X; Wang J; Li Y; Yao X
ACS Nano; 2023 Jun; 17(11):10313-10326. PubMed ID: 37141393
[TBL] [Abstract][Full Text] [Related]
38. Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.
Chen L; Tian B; Liu W; Liang H; You Y; Liu W
Front Oncol; 2022; 12():855674. PubMed ID: 35425715
[TBL] [Abstract][Full Text] [Related]
39. Integration of human inspection and artificial intelligence-based morphological typing of patient-derived organoids reveals interpatient heterogeneity of colorectal cancer.
Okamoto T; Natsume Y; Doi M; Nosato H; Iwaki T; Yamanaka H; Yamamoto M; Kawachi H; Noda T; Nagayama S; Sakanashi H; Yao R
Cancer Sci; 2022 Aug; 113(8):2693-2703. PubMed ID: 35585758
[TBL] [Abstract][Full Text] [Related]
40. The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model.
Bocuk D; Wolff A; Krause P; Salinas G; Bleckmann A; Hackl C; Beissbarth T; Koenig S
BMC Cancer; 2017 May; 17(1):342. PubMed ID: 28525976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
